Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Assessing the suitability of Norway spruce wood as an environmental archive for sulphur.

Barrelet T, Ulrich A, Rennenberg H, Zwicky CN, Krähenbühl U.

Environ Pollut. 2008 Dec;156(3):1007-14. doi: 10.1016/j.envpol.2008.05.004. Epub 2008 Jun 4.

PMID:
18534728
2.

Stability and reversibility of LiBH4.

Mauron P, Buchter F, Friedrichs O, Remhof A, Bielmann M, Zwicky CN, Züttel A.

J Phys Chem B. 2008 Jan 24;112(3):906-10. Epub 2007 Dec 19.

PMID:
18088111
3.

Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases.

Oppliger Leibundgut E, Horn MP, Brunold C, Pfanner-Meyer B, Marti D, Hirsiger H, Tobler A, Zwicky C.

Haematologica. 2006 Nov;91(11):1465-72.

4.

Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency.

Fontana S, Groebli R, Leibundgut K, Pabst T, Zwicky C, Taleghani BM.

Transfusion. 2006 Aug;46(8):1408-16.

PMID:
16934079
5.

cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis.

Vassina EM, Yousefi S, Simon D, Zwicky C, Conus S, Simon HU.

Eur J Immunol. 2006 Jul;36(7):1975-84.

6.

Trace metals in ambient air: Hourly size-segregated mass concentrations determined by synchrotron-XRF.

Bukowiecki N, Hill M, Gehrig R, Zwicky CN, Lienemann P, Hegedüs F, Falkenberg G, Weingartner E, Baltensperger U.

Environ Sci Technol. 2005 Aug 1;39(15):5754-62.

PMID:
16124312
7.

Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.

Oppliger Leibundgut E, Brunold C, Marti D, Horn MP, Seiler C, Schroeder V, Schmid JP, Tobler A, Zwicky C.

Haematologica. 2005 Jul;90(7):875-80.

8.

Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis.

Zahnd D, Leibundgut K, Zenhäusern R, Pabst T, Fontana S, Schneider R, Tobler A, Zwicky C.

Bone Marrow Transplant. 2004 Nov;34(10):847-53.

PMID:
15517005
9.

Real-time process/quality control for HPC processing.

Arpagaus M, Leibundgut EO, Zbären K, Brunold C, Ischi E, Tobler A, Zwicky C.

Cytotherapy. 2004;6(5):505-13.

PMID:
15512917
10.

Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.

Kremer Hovinga JA, Studt JD, Demarmels Biasiutti F, Solenthaler M, Alberio L, Zwicky C, Fontana S, Taleghani BM, Tobler A, Lämmle B.

Haematologica. 2004 Mar;89(3):320-4.

11.

Cerebral sinovenous thrombosis during asparaginase treatment. Case 3.

Leibundgut K, Hirt A, Zwicky C, Wuillemin WA.

Hamostaseologie. 2003 Aug;23(3):109-12.

PMID:
12923578
12.

The predictive value of clonogenic stem cell assays for the diagnosis of polycythaemia vera.

Zwicky C, Theiler L, Zbären K, Ischi E, Tobler A.

Br J Haematol. 2002 Jun;117(3):598-604.

PMID:
12028027
13.

Preparation and analysis of fetal liver extracts.

Zwicky C, Gerber S, Gasparini D, Forestier F, Hohlfeld P, Tissot JD, Schneider P.

Bone Marrow Transplant. 2000 Sep;26(6):667-71.

14.

[Autologous transplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I: patients].

Medinger P, Tissot JD, Nicoloso de Faveri G, Kovacsovics TJ, Perey L, Schneider P, Zwicky C.

Schweiz Med Wochenschr. 2000 Apr 1;130(13):478-84. French.

PMID:
10812643
15.

[Autologous transplantation of peripheral blood stem cells in the framework of treatment for hematologic neoplasms. II. Determination of CD34+ cells and progenitor colonies].

Medinger P, Schneider P, Nicoloso de Faveri G, Zwicky C, Tissot JD.

Schweiz Med Wochenschr. 2000 Apr 8;130(14):510-5. French.

PMID:
10804603
16.

[Prevention of post-transfusion cytomegalovirus infection: recommendations for clinical practice].

Zwicky C, Tissot JD, Mazouni ZT, Schneider P, Burnand B.

Schweiz Med Wochenschr. 1999 Jul 27;129(29-30):1061-6. French.

PMID:
10464908
18.

Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation.

Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P, Soiffer R, Ritz J, Nadler LM, Gribben JG.

Blood. 1996 Sep 15;88(6):2228-35.

Supplemental Content

Loading ...
Support Center